rejuvant life tabs

The Sheekey Science Show – Senolytics

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

This new senescence biomarker may help evaluate senolytic efficacy.

Senescent cells, also known as “zombie cells”, accumulate with age. There are many different ways in which a cell can become senescent, however, they share similar features including cell cycle arrest and the secretion of a variety of factors, referred to as the senescence associated secretory phenotype (SASP).

The Sheekey Science Show - Senolytics

Many of these factors are proinflammatory, and whilst thought to be useful for “senescence surveillance” whereby immune cells are recruited to remove senescent cells, if the cells are not cleared this can result in chronic inflammation which could have deleterious pro-aging effects. Due to our current understanding it has been hypothesised that clearance of senescent cells, using senolytics, could have therapeutic potential for alleviating symptoms of age-related diseases.

The Sheekey Science Show - Senolytics

Many senolytics, such as fisetin and dasatinib & quercetin are in early-stage clinical trials. Detecting senescent cells and evaluating the efficacy of these senolytics is currently challenging without using quite invasive procedures, yet this is invaluable for getting senolytics tested in trials. Therefore, it is exciting to see in a recent paper from the Buck Institute that they have identified a lipid, dihomo-15d-PGJ2 that accumulates in senescent cells but is only released (& detectable by plasma and urine samples) on senolysis.

The Sheekey Science Show - Senolytics

Therefore, dihomo-15d-PGJ2 may be a new senescence biomarker to help evaluate senolytic efficacy. Moreover, they show in this study that the accumulation of dihomo-15d-PGJ2 is not just a bystander of senescence, but actually plays a key role in promoting senescence development; in part this is due to the ability of dihomo-15d-PGJ2 to activate the protein Ras, a G-protein that has many downstream targets including my favourite protein p53. p53 can then activate the enzymes that generate dihomo-15d-PGJ2 and so you end up with a positive feedback loop reinforcing dihomo-15d-PGJ2 accumulation and senescence.

Elevant

Therefore, this study shows the importance of lipids, particularly a type of oxylipin, prostaglandins, in the development of senescence.

Elevant

Watch more Sheekey Science videos here.

Image credit: Hadrian / Shutterstock

Comment on this article

Phil Newman
Editor-in-Chief Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Exclusive interview with Alex Zhavoronkov

Insilico CEO on spreading the longevity message – the time is now. Dr Alex Zhavoronkov is the CEO and co-founder of Insilico Medicine, a pioneering AI...

Charles Brenner: the journey from NR to Tru Niagen

Dr Charles Brenner, the developer of the intellectual property behind ChromaDex's Tru Niagen, on all things metabolism, NAD and NR clinical trials. Longevity.Technology: Following the...

The Sheekey Science Show – Precision Medicine

What to expect for Precision medicine by 2030? All of us are unique. What may good for one persons health may be terrible for another's....

Biohacking our way back to physical events again

Tim Gray is the UK’s leading biohacking expert and founder/curator of the Health Optimisation Summit which takes place in London, 18-19 September: physical events...
Supps report ad middle